*001350482
*00520250613164559.0
*007ta
*008000914s1989    xxk           000 u eng
*00901058cam a2200205 c 4500
*019  $bl
*035  $a(EXLNZ-47BIBSYS_NETWORK)990011565864702201
*035  $a(NO-LaBS)17619634(bibid)
*035  $a(NO-TrBIB)001156586
*035  $a001156586-47bibsys_network
*040  $aNO-OsNB$bnob$ekatreg
*245  $aCountry studies
*260  $a[London]$bLondon School of Hygiene and Tropical Medicine$c1989
*300  $a1 b. (flere pag.)
*490  $aAn evaluation of WHO's Action Programme on Essential Drugs$vVol. 2
*500  $aOmhandler: Bangladesh, Colombia, Indonesia, Kenya, Nigeria, Sudan
*61027$aWorld Health Organization$bAction programme on essential drugs$0(NO-TrBIB)98034702$2bare$_63092300
*7102 $aWorld Health Organization$bAction programme on essential drugs$0(NO-TrBIB)98034702$_63092300
*830  $aAn evaluation of WHO's Action Programme on Essential Drugs$vVol. 2$_172339700
*901  $a80
*999  $aoai:nb.bibsys.no:990011565864702202$b2021-11-14T20:13:26Z$z990011565864702202
^